Cargando…
Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy
PURPOSE: The purpose of this study was to evaluate the impact of intraoperative MRI/TRUS fusion procedure in cT3a prostate cancer patients treated with high-dose-rate (HDR) real-time brachytherapy. MATERIAL AND METHODS: Prostate gland, dominant intraprostatic lesions (DILs), and extracapsular extens...
Autores principales: | Gomez-Iturriaga, Alfonso, Crook, Juanita, Casquero, Francisco, Carvajal, Claudia, Urresola, Arantxa, Canteli, Begoña, Ezquerro, Ana, Hortelano, Eduardo, Cacicedo, Jon, Espinosa, Jose Maria, Perez, Fernando, Minguez, Pablo, Bilbao, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105645/ https://www.ncbi.nlm.nih.gov/pubmed/25097555 http://dx.doi.org/10.5114/jcb.2014.43299 |
Ejemplares similares
-
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
por: Buchser, David, et al.
Publicado: (2016) -
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control
por: Mayrata, Esther, et al.
Publicado: (2021) -
MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021) -
MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
por: Gomez-Iturriaga, A., et al.
Publicado: (2020) -
A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy
por: Cacicedo, Jon, et al.
Publicado: (2014)